Tag Archive for: Product Development

Life Science Partner is pleased to announce the recruitment of Mark Adler, MBA to Canary Medical, where he will serve as Vice President of Product Development.

Canary Medical is an innovative medical technology company commercializing smart implants in the orthopedic, cardiovascular, and aesthetic markets. The company integrates a sensor and microprocessor system into FDA-cleared implantable medical devices to generate real-time insights about the performance and safety of these products.

Canary Medical logo

Adler will be driving further miniaturization and reduction of power for Canary’s implantable technology, advancing commercialization efforts in the orthopedic space, and providing technical support and management direction for the company’s cross function leadership to support its business objectives.

Mark was previously the Vice President at JenaValve Technologies, where he managed the development of the company’s next-gen aortic valve delivery system. He has consulted for companies such as Glucovation, Aortica, Nano-Structures, Medina Medical, Proteus Digital Health, and Micell Technologies. Among his many leadership positions, he was the Director of Sensor Engineering at Medtronic Diabetes, where he focused on the company’s glucose sensor. Also notable was his role at Dexcom as the Senior Director of Developmental Engineering and Operations, where he worked on their Class III continuous glucose monitoring system.

“Adler is well-versed in the transformation of early-stage to commercial ready technology,” notes Tom Callaway, Founder and President of Life Science Partner. “He has managed large and small research and development teams, with a heavy emphasis on later stage product development and manufacturing.”

Mark Adler earned a Bachelor of Technology Degree in Mechanical Engineering from Rochester Institute of Technology and an MBA from Argosy University in Seattle, WA.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Life Science Partner recruits former Vice President, Research and Development, Remote Patient Monitoring at Boston Scientific

Life Science Partner announces the recruitment of John Lalonde, an innovative senior medical device executive, to become Vice President, Product Development, Technology and Stimulation Research for Medtronic Neuromodulation. 

Neuromodulation is Medtronic’s second oldest and fourth largest business unit, with products that include neurostimulation systems and implantable drug delivery systems for chronic pain, common movement disorders, and urology and gastrointestinal disorders.

During his tenure at Boston Scientific, Lalonde was responsible for the development of LATITUDE, a cloud-based FDA class III home monitoring system for cardiac patients with wireless medical device implants treating arrhythmias and heart failure.  Previously, LaLonde served as General Manager, Global Engineering, Clinical Systems for GE Healthcare, where he was a global engineering leader of GE’s critical care business unit for neonatal, ICU, and OR patient monitoring and wireless cardiac monitoring systems.

In his new role at Medtronic Diabetes, Lalonde will be serve as the functional leader of Medtronic’s Neuromodulation Business Senior Leadership Team, to drive excellence in product development, technology and stimulation research.

“LaLonde is a talented engineering leader and innovator”, noted Tom Callaway, MD, founder and president of Life Science Partner.  “He has a depth of business knowledge and global commercialization experience that extends from value engineering to global customer reach.  He will bring leadership and quality execution to Medtronic’s Neuromodulation portfolio of stimulation and drug delivery solutions.”

LaLonde earned a Bachelor of Science Degree in Physics from the University of Minnesota and his Masters in Biomedical Engineering from the University of Wisconsin.

Learn More About Life Science Partner

Click button below to learn more about how we recruit Chief Executives:

Life Science Partner recruits Senior Cardiovascular Product Development Executive.

Life Science Partner announces the recruitment of Gene Jung, formerly Vice President of Engineering at ProRhythm, to the newly created Global Cardiovascular Innovation Center (GCIC) based in Cleveland, Ohio.

Headquartered on the campus of The Cleveland Clinic, GCIC was launched with a $60 million grant for the State of Ohio to develop and commercialize new cardiovascular products.  GCIC will utilize the considerable clinical, research and commercialization capabilities of the GCIC member organizations in northeast Ohio and focus on developing technologies in partnership with established cardiovascular-focused companies and in newly-formed start-up companies.

In Jung’s most recent role at ProRhythm, he was responsible for developing the company’s High Intensity Focused Ultrasound (HIFU) technology into a commercial product for Atrial Fibrillation.

Previously, Jung was a Medical Device Consultant in Tokyo where he designed and developed intra-vascular coronary products for numerous Japanese Medical Device Companies.   Prior to his work in Japan, Jung served as Research and Development Director at the Image Guided Therapy Division at Jomed Corporation in San Diego.

“Jung has a broad view of medical device technology from early-stage physician-driven innovation though product commercialization,” noted Tom Callaway, MD, founder and president of Life Science Partner. “His extensive technical leadership background across multiple cardiovascular platforms and his strong industry and physician networks will serve GCIC well.”

Jung earned his Bachelor of Science Degree in Mechanical Engineering from the University of Arizona in Tucson, AZ.

Life Science Partner recruits Innovative R&D Scientist.

Life Science Partner announces the recruitment of Shubhayu Basu, PhD, formerly Group Lead for New Business Ventures at Abbott Vascular, to the newly created Global Cardiovascular Innovation Center (GCIC) based in Cleveland, Ohio.

The organization was launched with a $60 million grant for the State of Ohio to develop and commercialize new cardiovascular products.  GCIC will focus on developing technologies in partnership with established cardiovascular-focused companies and in newly-formed start-up companies.

In Basu’s former role at Abbott Vascular (formerly Guidant), he was responsible for creating and implementing processes for identifying emerging technologies and various disease spaces and opportunities against the company portfolio and growth landscape.   Previously, he served as Group Lead, Research and Development, Cardiac Therapies for the company.

Prior to joining Guidant/Abbott, Basu was a Biodesign Innovation Fellow at Stanford University’s Biodesign Program in Palo Alto, CA.

“Basu will join another LSP recruit – Gene Jung – who shares his passion about new technologies and their application in patient care,” noted Tom Callaway, MD, founder and president of Life Science Partner.  “His ability to work with complex technologies to identify commercial opportunities and to oversee their development is a perfect fit for the GCIC team.”

Basu earned both his Bachelor and Masters Degree of Technology in Biochemical Engineering and Biotechnology at the Institute of Technology in New Delhi, India.  He received his PhD in Chemical Engineering at the Ohio State University in Columbus.